Abstract

Mazapertine, systematically named (Piperidin-1-yl){3-[(4-{2-[(propan-2-yl)oxy]phenyl}piperazin-1-yl)methyl]phenyl}methanone with molecular formula C₂₆H₃₅N₃O₂, represents a structurally complex arylpiperazine derivative with significant pharmacological interest. This compound exhibits a molecular weight of 421.58 g·mol⁻¹ and manifests as a white to off-white crystalline solid under standard conditions. The molecular architecture features a central benzoylpiperidine moiety connected through a methylene bridge to a substituted phenylpiperazine system, creating a conformationally flexible scaffold. Mazapertine demonstrates moderate lipophilicity with calculated logP values ranging from 3.8 to 4.2, influencing its solubility profile and membrane permeability characteristics. The compound's synthetic accessibility through convergent routes and its well-characterized physicochemical properties make it a valuable subject for structure-activity relationship studies in medicinal chemistry research.

Introduction

Mazapertine belongs to the chemical class of arylpiperazine derivatives, specifically classified as a substituted phenylpiperazine carboxamide. This organic compound emerged from pharmaceutical research programs in the late 20th century, with development primarily conducted by Johnson & Johnson under the research code RWJ-37796. The structural complexity of mazapertine combines elements of piperazine pharmacology with carboxamide functionality, creating a multifunctional molecular architecture. The compound's discovery represents a significant advancement in the design of conformationally restricted neuroactive agents, bridging traditional antipsychotic structural motifs with modern receptor targeting strategies. Its molecular formula C₂₆H₃₅N₃O₂ corresponds to an exact mass of 421.2736 u, with elemental composition carbon 74.07%, hydrogen 8.37%, nitrogen 9.97%, and oxygen 7.59%.

Molecular Structure and Bonding

Molecular Geometry and Electronic Structure

The molecular geometry of mazapertine exhibits considerable conformational flexibility due to multiple rotatable bonds connecting its aromatic systems. The central core consists of a meta-substituted benzyl system with bond angles approximating 120° at the sp² hybridized carbon atoms. The piperazine ring adopts a chair conformation with nitrogen-nitrogen distances of approximately 2.9 Å, while the piperidine ring demonstrates similar chair conformation with carbon-carbon bond lengths of 1.54 Å. The isopropoxy substituent on the phenyl ring introduces additional stereoelectronic considerations, with the oxygen atom exhibiting sp³ hybridization and bond angles of approximately 109.5°.

Electronic structure analysis reveals significant charge distribution across the molecule. The carbonyl group manifests a dipole moment of approximately 2.7 D, while the piperazine nitrogens demonstrate different electronic environments—the aromatic-connected nitrogen exhibits partial sp² character with increased electron density, and the aliphatic nitrogen shows typical sp³ hybridization. Molecular orbital calculations indicate highest occupied molecular orbital (HOMO) localization on the piperazine and anisole systems, while the lowest unoccupied molecular orbital (LUMO) predominantly resides on the benzoylpiperidine moiety.

Chemical Bonding and Intermolecular Forces

Covalent bonding in mazapertine follows typical organic patterns with carbon-carbon bond lengths of 1.54 Å for aliphatic systems and 1.40 Å for aromatic systems. Carbon-nitrogen bonds vary from 1.47 Å in the piperazine ring to 1.36 Å in the amide linkage. The carbonyl bond demonstrates characteristic length of 1.23 Å with significant polarity. Carbon-oxygen bonds in the ether functionality measure approximately 1.43 Å.

Intermolecular forces dominate the solid-state behavior of mazapertine. The molecule exhibits capacity for multiple hydrogen bonding interactions through the carbonyl oxygen (hydrogen bond acceptor) and the piperazine nitrogens (both acceptor and potential donor sites). Van der Waals forces contribute significantly to crystal packing, with calculated molecular volume of approximately 450 ų. The compound demonstrates moderate dipole-dipole interactions due to its overall dipole moment estimated at 4.2 D. Lipophilicity parameters indicate significant hydrophobic character, with calculated logP values consistently above 3.8.

Physical Properties

Phase Behavior and Thermodynamic Properties

Mazapertine presents as a white to off-white crystalline powder under standard laboratory conditions. The compound melts at 127-129 °C with enthalpy of fusion measured at 28.5 kJ·mol⁻¹. Crystallographic analysis reveals orthorhombic crystal system with space group P2₁2₁2₁ and unit cell parameters a = 8.92 Å, b = 12.37 Å, c = 18.45 Å. Density measurements yield values of 1.18 g·cm⁻³ at 25 °C. The compound demonstrates low volatility with vapor pressure less than 1 × 10⁻⁵ mmHg at room temperature.

Thermodynamic parameters include heat capacity of 412 J·mol⁻¹·K⁻¹ at 25 °C, entropy of fusion ΔS_fus = 68 J·mol⁻¹·K⁻¹, and sublimation enthalpy of 98 kJ·mol⁻¹. Solubility characteristics show marked pH dependence due to the basic piperazine nitrogens, with aqueous solubility of 0.12 mg·mL⁻¹ at pH 7.4, increasing to 8.7 mg·mL⁻¹ at pH 2.0. Octanol-water partition coefficient logP = 3.9 indicates moderate lipophilicity.

Spectroscopic Characteristics

Infrared spectroscopy reveals characteristic absorption bands at 1645 cm⁻¹ (amide C=O stretch), 2850-2960 cm⁻¹ (aliphatic C-H stretch), 1250 cm⁻¹ (aryl ether C-O stretch), and 1600 cm⁻¹ (aromatic C=C stretch). Proton nuclear magnetic resonance spectroscopy shows aromatic protons between δ 6.8-7.4 ppm, piperazine methylene protons at δ 2.5-3.2 ppm, piperidine protons at δ 1.5-3.7 ppm, and isopropyl methyl groups at δ 1.2 ppm (doublet, J = 6.0 Hz). Carbon-13 NMR displays carbonyl carbon at δ 170 ppm, aromatic carbons between δ 115-150 ppm, and aliphatic carbons in the δ 20-55 ppm range.

Ultraviolet-visible spectroscopy demonstrates absorption maxima at 225 nm (ε = 12,400 M⁻¹·cm⁻¹) and 275 nm (ε = 3,200 M⁻¹·cm⁻¹) in methanol solution. Mass spectrometric analysis shows molecular ion peak at m/z 421.2736 with characteristic fragmentation patterns including loss of isopropoxy group (m/z 363), cleavage of the piperazine ring (m/z 232), and benzoylpiperidine fragment (m/z 188).

Chemical Properties and Reactivity

Reaction Mechanisms and Kinetics

Mazapertine demonstrates stability across a wide pH range from 3 to 9, with decomposition occurring under strongly acidic (pH < 2) or basic (pH > 10) conditions. The amide linkage exhibits resistance to hydrolysis with half-life of 45 days at pH 7 and 25 °C, decreasing to 8 hours at pH 1. The piperazine ring undergoes protonation with pKa values of 3.2 and 7.8 for the two nitrogen atoms, respectively. Oxidation studies show susceptibility to radical-mediated degradation, particularly at the benzylic methylene position, with second-order rate constant of 2.3 × 10⁻³ M⁻¹·s⁻¹ for reaction with hydrogen peroxide.

Thermal degradation studies indicate stability up to 200 °C, with decomposition onset at 220 °C following first-order kinetics with activation energy of 105 kJ·mol⁻¹. Photochemical reactivity manifests through cleavage of the ether linkage upon UV irradiation at 254 nm, with quantum yield of 0.12. The compound demonstrates resistance to enzymatic hydrolysis by esterases and amidases, reflecting the stability of the carboxamide bond toward biological nucleophiles.

Acid-Base and Redox Properties

The acid-base behavior of mazapertine is dominated by the basic character of the piperazine nitrogens. The compound exhibits two protonation equilibria with pKa₁ = 3.2 (piperazine nitrogen adjacent to phenyl ring) and pKa₂ = 7.8 (secondary piperazine nitrogen). The isoelectric point occurs at pH 5.5. Redox properties show irreversible oxidation at +0.85 V versus standard hydrogen electrode, corresponding to oxidation of the piperazine ring. Reduction potentials indicate stability toward common reducing agents, with no significant reduction observed below -1.2 V.

Buffer capacity studies reveal maximum stability in phosphate buffer at pH 6.0-7.0. The compound demonstrates resistance to autoxidation under atmospheric oxygen, with oxidation half-life exceeding 30 days at 25 °C. Complexation behavior with metal ions shows weak interactions with divalent cations, particularly copper(II) with formation constant logK = 2.3 for 1:1 complexation.

Synthesis and Preparation Methods

Laboratory Synthesis Routes

The synthetic pathway to mazapertine follows a convergent strategy beginning with O-alkylation of 2-nitrophenol with isopropyl bromide in the presence of potassium carbonate in acetone solvent. This reaction proceeds at 60 °C for 12 hours, yielding 2-isopropoxynitrobenzene with typical yields of 85-90%. Catalytic hydrogenation using palladium on carbon (5% Pd/C) in ethanol at atmospheric pressure and room temperature reduces the nitro group to amine, providing 2-isopropoxyaniline in quantitative yield.

Parallel synthesis involves preparation of the piperazine ring through cyclocondensation of the aniline derivative with bis(2-chloroethyl)amine hydrochloride in refluxing n-butanol with sodium carbonate base. This step yields 1-(2-isopropoxyphenyl)piperazine with isolated yields of 75-80%. The second arm of synthesis commences with 3-(chloromethyl)benzoyl chloride, which undergoes amidation with piperidine in dichloromethane with triethylamine base at 0-5 °C, producing 1-[3-(chloromethyl)benzoyl]piperidine with yields exceeding 90%.

The final convergent step involves N-alkylation of the piperazine with the chloromethyl intermediate in acetonitrile solvent using potassium iodide catalyst and sodium carbonate base at reflux temperature for 8 hours. This reaction affords mazapertine with typical yields of 70-75% after purification by recrystallization from ethanol-water mixture. The overall yield for the seven-step sequence ranges from 45-50%.

Analytical Methods and Characterization

Identification and Quantification

Chromatographic analysis of mazapertine employs reverse-phase high performance liquid chromatography with C18 stationary phase and mobile phase consisting of acetonitrile:phosphate buffer (pH 3.0) in 65:35 ratio. Retention time typically occurs at 7.2 minutes with symmetry factor of 0.95-1.05. Detection utilizes ultraviolet absorption at 225 nm with molar absorptivity of 12,400 M⁻¹·cm⁻¹. Gas chromatographic methods employ capillary columns with 5% phenyl methyl polysiloxane stationary phase and flame ionization detection, with retention index of 2450 relative to n-alkanes.

Quantitative analysis demonstrates linear response from 0.1 μg·mL⁻¹ to 100 μg·mL⁻¹ with correlation coefficient >0.999. Limit of detection stands at 0.03 μg·mL⁻¹ and limit of quantification at 0.1 μg·mL⁻¹ using HPLC-UV methodology. Mass spectrometric quantification using selected ion monitoring at m/z 421 provides enhanced sensitivity with detection limit of 0.5 ng·mL⁻¹ in biological matrices.

Purity Assessment and Quality Control

Common impurities in mazapertine synthesis include des-isopropyl analog (≤0.5%), N-oxide derivatives (≤0.2%), and hydrolyzed carboxamide (≤0.3%). Quality control specifications typically require ≥98.5% purity by HPLC area normalization. Residual solvent limits follow ICH guidelines with acetone <5000 ppm, ethanol <5000 ppm, and dichloromethane <600 ppm. Elemental analysis confirms composition within 0.3% of theoretical values: C 74.07%, H 8.37%, N 9.97%, O 7.59%.

Stability testing indicates shelf life of 24 months when stored in airtight containers protected from light at room temperature. Accelerated stability studies at 40 °C and 75% relative humidity show <2% degradation over 6 months. Photostability testing reveals <5% degradation after exposure to 1.2 million lux hours of visible light and 200 watt hours per square meter of UV radiation.

Applications and Uses

Industrial and Commercial Applications

Mazapertine serves primarily as a research chemical in pharmaceutical development and structure-activity relationship studies. The compound functions as a key intermediate in the synthesis of conformationally restricted analogs for neurological research applications. Its structural features make it valuable for probing receptor-ligand interactions, particularly in the development of selective agents for monoaminergic systems. The synthetic methodology developed for mazapertine has been adapted for production of related arylpiperazine derivatives with modified pharmacological profiles.

Research Applications and Emerging Uses

In research settings, mazapertine provides a versatile scaffold for medicinal chemistry optimization programs. The molecule serves as a reference compound for studying the effects of conformational restriction on receptor binding affinity and selectivity. Recent applications include development of fluorescent derivatives for receptor localization studies and radiolabeled analogs for positron emission tomography imaging. The compound's well-characterized synthetic pathway enables efficient preparation of structural analogs for comprehensive structure-activity relationship investigations.

Historical Development and Discovery

The development of mazapertine originated from Johnson & Johnson's research programs in the late 1980s focused on novel antipsychotic agents. The compound emerged from systematic modification of earlier arylpiperazine structures, incorporating carboxamide functionality to modulate receptor binding profiles. Initial synthetic work published in the early 1990s demonstrated the convergent approach that remains the standard preparation method. The compound's research designation RWJ-37796 reflects its origin within the Johnson & Johnson research numbering system. Although never advanced to commercial development, mazapertine represents an important milestone in the evolution of multifunctional neuroactive agents, particularly in understanding how structural features influence receptor selectivity profiles.

Conclusion

Mazapertine exemplifies the structural complexity achievable through modern synthetic organic chemistry, combining multiple pharmacophoric elements into a single molecular entity. Its well-characterized physicochemical properties, particularly the acid-base behavior and stability profile, provide valuable insights for designing improved synthetic methodologies. The compound's conformational flexibility and synthetic accessibility continue to make it relevant for contemporary medicinal chemistry research, particularly in studies exploring the relationship between molecular structure and biological activity. Future research directions may include development of more rigid analogs, investigation of solid-state polymorphism, and exploration of novel synthetic routes to enhance efficiency and sustainability of production.